Upstream therapeutic strategies of valsartan and fluvastatin on hypertensive patients with non-permanent atrial fibrillation-Reference-Cited by-同舟云学术

Upstream therapeutic strategies of valsartan and fluvastatin on hypertensive patients with non-permanent atrial fibrillation

Published:2018-11-28 Issue:6 Volume:36 Page:e12478
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:Cardiovasc Ther

Author:

Zhao Zhiqiang¹,Niu Xiaowei¹,Dong Zhaojie¹,Qi Wenwei¹,Liu Enzhao¹,Liu Tong¹^ORCID,Li Lifeng¹,Liang Yingzi¹,Li Guangping¹^ORCID

Affiliation:

1. Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology; Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University; Tianjin China

Funder

Key Laboratory Science Fundation of Second Hospital of Tianjin Medical University

Tianjin Science and Technology Committee

Natural Science Foundation of Tianjin City

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1755-5922.12478/fullpdf

Reference42 articles.

1. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study;Chugh;Circulation,2014

2. Acute management of atrial fibrillation: from emergency department to cardiac care unit;Atzema;Cardiol Clin,2018

3. Atrial fibrillation and hypertension: mechanistic, epidemiologic, and treatment parallels;Ogunsua;Methodist Debakey Cardiovasc J,2015

4. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics;Magnani;Circulation,2011

5. Atrial remodeling and atrial fibrillation: mechanisms and implications;Nattel;Circ Arrhythm Electrophysiol,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remodeling in Persistent Atrial Fibrillation: Pathophysiology and Therapeutic Targets—A Systematic Review;Physiologia;2023-01-09

2. Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis;Cardiovascular Therapeutics;2021-05-17

3. Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial;Clinical Cardiology;2020-10-26

4. Antiarrhythmic Properties of Non-Antiarrhythmic Drugs in Atrial Fibrillation: Upstream Therapy;Antiarrhythmic Drugs;2020

5. Anti-arrhythmic Effects of Non-anti-arrhythmic Drugs or Therapies;Contemporary Cardiology;2020